<unk>  has mostly been studied in combination with an estrogen, so the side effects of<unk>  specifically or on its own have not been well-defined. Side effects associated with the combination of ethinylestradiol and<unk>  as a transdermal patch in premenopausal women, with greater than or equal to 2.5% incidence over 6 to 13 menstrual cycles, include breast symptoms (including discomfort, engorgement, and/or pain; 22.4%), headaches (21.0%), application site reactions (17.1%), nausea (16.6%), abdominal pain (8.1%), dysmenorrhea (7.8%), vaginal bleeding and menstrual disorders (6.4%), mood, affect, and anxiety disorders (6.3%), vomiting (5.1%), diarrhea (4.2%), vaginal yeast infections (3.9%), dizziness (3.3%), acne (2.9%), migraine (2.7%), weight gain (2.7%), fatigue (2.6%), and pruritus (2.5%).
Norelgestromin
Levonorgestrel
Chloroethynylnorgestrel
Gestodene
5α-Dihydrolevonorgestrel
Ethinylestradiol sulfonate
Etonogestrel
Telapristone